APA

Nishizawa K., Yano T., Tanno M., Miki T., Kuno A., Tobisawa T., Ogasawara M., Muratsubaki S., Ohno K., Ishikawa S. & Miura T. (20170807). Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size. : Hypertension (Dallas, Tex. : 1979).

Chicago

Nishizawa Keitaro, Yano Toshiyuki, Tanno Masaya, Miki Takayuki, Kuno Atsushi, Tobisawa Toshiyuki, Ogasawara Makoto, Muratsubaki Shingo, Ohno Kouhei, Ishikawa Satoko and Miura Tetsuji. 20170807. Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size. : Hypertension (Dallas, Tex. : 1979).

Harvard

Nishizawa K., Yano T., Tanno M., Miki T., Kuno A., Tobisawa T., Ogasawara M., Muratsubaki S., Ohno K., Ishikawa S. and Miura T. (20170807). Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size. : Hypertension (Dallas, Tex. : 1979).

MLA

Nishizawa Keitaro, Yano Toshiyuki, Tanno Masaya, Miki Takayuki, Kuno Atsushi, Tobisawa Toshiyuki, Ogasawara Makoto, Muratsubaki Shingo, Ohno Kouhei, Ishikawa Satoko and Miura Tetsuji. Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size. : Hypertension (Dallas, Tex. : 1979). 20170807.